TESLA HAMPTON: Open Payments
NPI 1942764147 · BELLAIRE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,044 in 153 payments from 15 companies in 2025. Trend: 2023 $1,298 · 2024 $1,394 · 2025 $3,044
Food & beverage: $3,044
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $658 |
| Madrigal Pharmaceuticals | 24 | $473 |
| PFIZER INC. | 24 | $379 |
| Phathom Pharmaceuticals, Inc. | 15 | $314 |
| GENZYME CORPORATION | 8 | $262 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $249 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $177 |
| Janssen Biotech, Inc. | 7 | $165 |
| Regeneron Healthcare Solutions, Inc. | 4 | $79 |
| Gilead Sciences, Inc. | 4 | $76 |
Products named: REZDIFFRA, DUPIXENT, VOQUEZNA, XIFAXAN, VELSIPITY, ENTYVIO, XELJANZ, TREMFYA.
Industry payments across OH — which companies pay providers there.
